An essential and complete guide for the biotechnology companies operating in Singapore.

Industry Articles

Preface

New drugs and disease treatments that improve patient outcomes are often the results of innovations in the biomedical sciences field. Many of these innovations are made possible because of advanced R&D tools used by researchers. These R&D tools are critical and are akin to the shovels and buckets used by the early prospectors discovering gold during the gold rush. Sometimes, major advancements in R&D tools even create research paradigm shifts that changes the industry’s approach to research and development.

In our Special Feature for this edition of the Singapore PharmBio Guide, we want to bring Singapore’s R&D tool sub-sector into focus and highlight its significant contribution to the economy and the outsized role it plays in the global biomedical sciences research landscape. We have profiled a few of the leading international R&D tool companies that have made Singapore their home-base. Through these profiles, we hope readers will have a better understanding of the local biomedical sciences scene and discover how Singapore is providing a conducive environment for these companies to thrive and grow their business in Asia and beyond.

Furthermore, we have since revamped our portal (www.pharmbiosingapore.com) and will now offer the entire Guide as an eBook on our site. This online version will start to replace the paper copies that we have diligently published over the past 17 years. The entire Guide is now available to everyone round the clock so long as one has access to the internet and a web browser. The weblinks in the Guide are now clickable, making it much easier for readers to find additional information from various sources. We have also revamped our products and services listings on the portal to promote B2B activities. We will continue to tap on web technology to make the site even more useful, informative and user friendly.

We remain grateful to our various partners, including the continual support of the Singapore Economic Development Board (EDB), both as a key contributor of editorial content and as an important distribution channel through the EDB offices worldwide. And as always, we would like to thank our advertisers for their loyal support and we hope that you will continue to find this guide relevant. We appreciate any comment or feedback that will help us improve our publication further. Do feel free to drop us an email at biotechguide@1st-phase.com.

Co-Editors

Derrick Tan, Ph.D.
Managing Consultant
1st Phase Operations

Marvin Ng, MBA
Business Development Consultant
Greener Grass Communications